FDA advisory committee recommends approval of Novartis' Afinitor for advanced pancreatic NET April 13, 2011
IND application filed for mTOR/PI3K-alpha inhibitor PWT-33597 based on in vivo antitumor action April 13, 2011
Pfizer to supply Sutent for immatics' phase III IMA-901 trial in advanced renal cell cancer April 12, 2011
RSS